Skip to main content
Premium Trial:

Request an Annual Quote

GSK Extends Adverse-Event Pharmacogenomics Pact with FGT

NEW YORK, May 25 (GenomeWeb News) - First Genetic Trust said today that it will use its enTrust genetic banking platform in a research collaboration with GlaxoSmithKline to study the relationship between genetic variations and certain adverse drug reactions.

 

The companies entered a similar collaboration in October 2001. FGT called the new agreement a "further research collaboration" with GSK, but did not provide details on whether the expanded effort is a renewal of the original agreement or a new project.   

 

FGT said that GSK will use enTrust to collect, store, and manage patient enrollment, informed consent, and clinical data to support the project.

 

The system will also be used to re-contact patients online for additional consent for new research or phenotypic information, FGT said.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.